Lyme disease and other tick-related illnesses have become a public health concern, and the risk increases as the weather warms up. While death from Lyme disease is rare, it is possible.
The beginning of the Covid-19 pandemic in 2020 provided the spark that catapulted mRNA vaccine technology into the public spotlight and consciousness. Last November, Rich Haridy reported that research is underway to determine the feasibility of developing an mRNA vaccine that can protect against the potential harm of a tick bite.
A new study published in the journal Science Translational Medicine is reporting the development of a novel mRNA-based vaccine designed to help resist tick bites. Preclinical tests in guinea pigs indicate the vaccine aids the immune system in recognizing tick bites, resulting in the parasites being dislodged before they can transmit any pathogenic disease.Rich Haridy, “New mRNA anti-tick vaccine may protect from more than just Lyme disease,” New Atlas, November 17, 2021